Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Immunogenicity, security and protection against small ruminant lentivirus (SRLV) challenge in sheep, induced by intranasal immunization with a recombinant Sendai virus vector expressing SRLV gag-P25

  • Gómez, Álex
  • Reina, R.
  • Glaría Ezquer, Idoia
  • Moncayola, Irati
  • Echeverría Garín, Irache
  • Rodríguez Largo, Ana
  • Blas, Ignacio de
  • Pérez, Estela
  • Pérez, Marta María
  • Villanueva-Saz, Sergio
  • Lee, Benhur
  • Diego, Alicia de
  • Miguel, Ricardo de
  • Luján, Lluís
Small ruminant lentiviruses (SRLV) are responsible for significant economic losses in sheep and goat farming; however, effective vaccination strategies remain unavailable. This study evaluated the immunogenicity, safety, and protective efficacy of a recombinant Sendai virus vector (SeV) expressing SRLV gag-P25 (rSeV-GFP-P25) in lambs. Twenty-one SRLV-negative lambs were divided into three groups and inoculated intranasally thrice with culture medium (group 1); SeV-GFP (group 2) or rSeV-GFP-P25 (group 3). Lambs were challenged with homologous SRLV at 16 weeks post-first immunization. Clinical and hematological parameters, antibody responses, SRLV viral loads in peripheral blood mononuclear cells (PBMCs) and target tissues, histopathological and histomorphometric analyses, assisted with artificial intelligence, of interstitial pneumonia were assessed. No clinicopathological alterations were observed, except for a transient temperature increase in group 3 post-first immunization. Group 2 showed mild SeV-neutralizing antibodies, while rSeV-GFP-P25 (group 3) induced negligible SRLV-specific antibody responses. Group 3 exhibited higher SRLV DNA copies in PBMCs but lower in most SRLV target tissues compared to control groups, with no SRLV DNA detected in spleen and bone marrow. Histomorphometry revealed reduced alveolar septal thickening in group 3, indicating partial protection against early SRLV-associated interstitial pneumonia. These results warrant further investigation into cellular immunity and long-term protection., This study was funded by a grant from the Ministerio de Ciencia, Innovación y Universidades, Government of Spain under Grant RTI2018-096172-B-C33. Gobierno de Navarra (PC24-ECTIVAC-002-017-018). Álex Gómez is a PhD candidate funded by the Gobierno de Aragón [ORDEN CUS/803/2021]. We are grateful to Centro de Investigación Biomédica de Aragón (CIBA) for the assistance in the scanning of histopahological samples.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

The whole genome analysis of four Orf virus strains from Europe and South America

  • Cacciabue, Marco
  • Lozano Calderón, Laura C.
  • Moleres Apilluelo, Javier
  • Echeverría Garín, Irache
  • Pablo Maiso, Lorena de
  • Glaría Ezquer, Idoia
  • König, Guido
  • Peralta, Andrea
  • Reina Arias, Ramsés
Orf virus (ORFV) is the etiological agent of Contagious Ecthyma, a global disease that mainly affects sheep, goats, wild ruminants, and humans. Here, we determined the complete genome sequence of two ORFV strains from Spain (NAV and ARA) and two from Argentina (HRE and CHB), representing the first report from the Iberian Peninsula and from South America. The assembled genomes of the ARA, CHB, HRE, and NAV strains of ORFV were found to be 137891 , 137160, 137340, and 137214 bp long, respectively, each contained 132 genes,and all showed high amino-acid identity and similar lengths compared to the reference strain NZ2.We performed a microsatellite analysis to identify molecular signatures associated with host species (sheep or goat). In addition, the analysis of 32 selectedgenesshowedthatthemediannucleotidesubstitutionratefortheworldwidecluster3thatincludesthefoursamplesdescribed in this study, was 2.6 x10−5 subs/site/year (9.2x10−8—6.7x10−5—95% HPD) placing the TMRCA (median divergence time) around 1730. Genetic characterization of ORFV strains not only allows epidemiological studies but also represents the f irst step towards developing molecular tools for diagnostics and vaccines., PICT2017–2728 from Agencia de Promoción Científica y Tecnológica, Argentina; PC080–081 ECTICONA and PC24-ECTIVAC-002-017-018 from Gobierno de Navarra.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

In vitro antiviral properties of two recombinant sendai virus vectors encoding ORFV 011 and ORFV 059 genes

  • Gómez, Álex
  • Glaría Ezquer, Idoia
  • Moncayola, Irati
  • Puzol, Leonor
  • Arriazu Pardo, Laura
  • Calero, Ainhoa
  • Blas, Ignacio de
  • Nazábal, Mikel
  • Hualde, Itziar
  • Lee, Benhur
  • Luján, Lluís
  • Amann, Ralf
  • Echeverría Garín, Irache
  • Reina Arias, Ramsés
Orf virus (ORFV) is a globally distributed zoonotic parapoxvirus that causes a highly contagious mucocutaneous disease in small ruminants. Despite the urgent demand for vaccination-based control, no licensed vaccines are currently available universally. In this study, we generated two recombinant Sendai virus (SeV) vectors expressing ORFV 011 (rSeV-GFP-B2L) and ORFV 059 (rSeV-GFP-059) genes and evaluated their ability to stimulate antiviral responses in vitro. Following the transduction, we assessed transgene expression, innate immune activation, induction of interferon-stimulated genes (A3Z1, OBST2, SAMHD1), and antiviral activity. Both vectors significantly upregulated pattern recognition receptors (TLRs, RIG-I) and type I interferon (IFN-β) genes, with rSeV-GFP-059 inducing the strongest response. Remarkably, OBST2 was robustly upregulated, suggesting a potential role in restricting ORFV replication. Antiviral activity assays revealed a marked reduction in ORFV DNA copies and a mild decrease in ORFV RNA transcription in rSeVGFP-059-transduced cells, particularly at later time points, accompanied by complete abrogation of the typical cytopathic effect. Collectively, these results demonstrate that SeV-based vectors, particularly rSeV-GFP-059, efficiently prime antiviral immunity and suppress ORFV replication, establishing a promising platform for further in vivo vaccine evaluation in sheep., This research was funded by the Gobierno de Navarra, grant number PC080-081 ECTICONA and PC24-ECTIVAC-002-017-018